The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

More than 15.5 million Americans have tried weight loss injectables, but risks are rising with the proliferation of ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Clinical neuroscientist Joe Schacht offered an overview of the research on weight-loss drugs for alcoholism, other potential ...

“With a glycemic index of 15, chili peppers contain capsaicin. Capsaicin has been shown to mildly boost metabolism while ...

The resolution comes two months after the health regulator said there was no longer a shortage of Eli Lilly's weight-loss and ...

He has been critical of the boom in weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro. Kush Desai, a White House spokesman, said the order follows concerns about doctors ...

Modern weight loss treatments have transformed how we approach obesity management, but they come with concerning side effects. The growing use of glucagon-like peptide-1 medications has ...

For customers using a telehealth website to get cheaper versions of popular obesity drugs, the low prices ... to talk to one another during their weight-loss journeys. The Zappy chat was ...

The "Hims and Hers" commercial railed against the weight loss industry and promoted the company's weight loss drug offerings as a less costly option compared to brand-name drugs. Eli Lilly’s ...